Holen Sie sich die Stockscreener-App
2.33
4.68%
-0.11
Finanzdaten der Context Therapeutics Inc-Aktie (CNTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Income/Loss |
8.73%
-10.61
|
-9.7584 | -5.5291 | -4.3104 | -18.70 |
| Income/Loss From Continuing Operations Before Tax |
9.81%
-9.6932
|
-8.8275 | -4.5773 | -28.96 | 1.2437 |
| Income/Loss From Continuing Operations After Tax |
9.81%
-9.6932
|
-8.8275 | -4.5773 | -3.3429 | -17.46 |
Net Income/Loss
|
9.81%
-9.6932
|
-8.8275 | -4.5773 | -3.3429 | -17.46 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.00%
95.19
|
95.19 | 95.19 | 7.838 | 80.48 |
| Diluted Average Shares |
0.00%
95.19
|
95.19 | 95.19 | 7.838 | 80.48 |
| Basic Earnings Per Share |
11.11%
-0.10
|
-0.09 | -0.05 | - | -0.22 |
| Diluted Earnings Per Share |
11.11%
-0.10
|
-0.09 | -0.05 | - | -0.22 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.78%
3.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):